Evidence Boundary Most studied route in the Phase 2 program, but the OPTIONS trial missed its primary weight-loss endpoint and development was terminated in 2007
A 2.5 mg dose at 15 mg/mL requires drawing only about 16.7 units
Patients should be reviewed 812 weeks after commencing treatment to assess: Symptomatic improvement, particularly resolution of fatigue and neurological symptoms Haematological response (normalisation of haemoglobin and mean cell volume) Reticulocyte count typically rises within one week, indicating bone marrow response Repeat serum B12 testing is generally not useful after starting parenteral therapy, as levels remain elevated for months
These people know their stuff, and theyre willing to share
VITAMIN INJECTIONS Vitamin injection therapy is an effective, rapid treatment designed to administer essential nutrients directly into the bloodstream, ensuring optimal absorption
Phase 1: Activation (Weeks 14) Dose: Daily GHK-Cu supplies the collagen signal and supports structural cross-linking BPC-157 supports the capillary network that feeds active tissue TB-4 mobilizes and organizes repair cells Baseline photos
